(28 days)
No
The description focuses on basic visualization and measurement tools, and there is no mention of AI or ML in the text or the "Mentions AI, DNN, or ML" field.
No
The device is described for "basic visualization of medical images that are used for diagnostic purposes" and for "measurements" and "analysis of clinical data," which are diagnostic functions, not therapeutic ones.
Yes
Justification: The "Intended Use / Indications for Use" section explicitly states that "syngo. CT View&GO is intended for basic visualization of medical images that are used for diagnostic purposes." The device helps in the analysis of clinical data and supports trained technicians and trained physicians in basic qualitative and basic quantitative measurements, which are crucial aspects of diagnostic processes.
Yes
The description explicitly states "The application syngo.CT View&GO is intended for basic visualization of medical images..." and details software functionalities like visualization, measurements, and data transfer. There is no mention of accompanying hardware components being part of the device itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
- Device Function: syngo.CT View&GO is a software package designed for the visualization and analysis of medical images acquired from Computed Tomography (CT) scanners. It performs tasks like adjusting image display, making measurements on the images, and transferring image data.
- Lack of Biological Sample Analysis: The description clearly states that the software works with "clinical data that has been acquired and reconstructed on Computed Tomography scanners." This data is image-based, not derived from biological samples.
Therefore, since the device does not perform tests on biological samples, it does not fit the definition of an In Vitro Diagnostic device. It is a medical image processing and visualization software.
N/A
Intended Use / Indications for Use
syngo.CT View&GO is intended for basic visualization of medical images that are used for diagnostic purposes. The software package is designed to support trained technicians and trained physicians in basic qualitative and basic quantitative measurements as well as in the analysis of clinical data that has been acquired and reconstructed on Computed Tomography scanners. The software package shall also provide the possibility to save image data and to trigger the transfer of image data to other systems, such as printers or archiving systems. The software package shall provide an interface to integrate additional advanced visualization and measurement tools.
Basic visualization of medical images includes, for example:
- Adjusting of windowing level presets
- Zooming and panning of images
- Multiplanar reconstruction (MPR) display
- Maximum intensity projection (MIP) display
- Volume rendering techniques (VRT) display
Basic qualitative and basic quantitative measurements include, for example:
- Distance measurements
- Region of interest (ROI) measurements
- Pixel lens to measure local HU values
Product codes (comma separated list FDA assigned to the subject device)
LLZ, 90JAK
Device Description
The application syngo.CT View&GO is intended for basic visualization of medical images that are used for diagnostic purposes. It is designed to support trained technicians and trained physicians in basic qualitative and basic quantitative measurements as well as in the analysis of clinical data that has been acquired and reconstructed on Computed Tomography scanners. The application also provides the possibility to save image data and to trigger the transfer of image data to other systems, such as printers or archiving systems. In addition, syngo.CT View&GO provides an interface to integrate additional advanced post processing tools through the plug-in functionality of syngo.CT View&GO.
The application provides the basic visualization features (for example):
- Adjusting of windowing level presets
- Zooming and panning of images
- Multiplanar reconstruction (MPR) display
- . Maximum intensity projection (MIP) display
- Volume rendering techniques (VRT) display
Furthermore, basic qualitative and quantitative measurements are supported (for example):
- Distance measurements
- Region of interest (ROI) measurements
- Pixel lens to measure local HU values
syngo.CT View&GO also provides an interface to extend this application for additional advanced post processing tools through the plug-in functionality of syngo.CT View&GO.
This subject device contains the following modifications/improvements in comparison to the predicate device syngo®.via (version VB10A):
-
- New marketing name: syngo.CT View&GO
-
- Modified Indications for Use Statement
-
- Software version SOMARIS/8 VB20A which supports for following:
- o Extensibility (modified)
- Visualization tools (improved) o
- o Workflow and arrangement of commonly utilized tools (improved)
- Distribution of images in DICOM node (improved) O
The subject device syngo.CT View&GO is designed to operate on a syngo compatible host system (e.g. syngo.via VB20 software platform or higher). A comparison of these modifications with respect to the predicate device is provided in the "Comparison pf Technological Characteristics with the Predicate Device" section below.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Computed Tomography
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained technicians and trained physicians
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Non-clinical tests (integration and functional) were conducted for syngo.CT View&GO during product development. The modifications described in this Premarket Notification were supported with verification/validation testing. Verification and Validation testing for the endoscopic view feature was conducted to demonstrate successful software integration and performance in accordance to Siemens internal procedure which includes risk identification and mitigation in accordance with ISO 14971. All verification testing has been completed and meets Siemens acceptance criteria. Additionally, all risks for the complete subject device have been identified and mitigated accordingly.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following performance data were provided in support of the substantial equivalence determination. This submission contains performance data to demonstrate conformance with special controls for medical devices containing software. Non-clinical tests (integration and functional) were conducted for syngo.CT View&GO during product development. The modifications described in this Premarket Notification were supported with verification/validation testing. Verification and Validation testing for the endoscopic view feature was conducted to demonstrate successful software integration and performance in accordance to Siemens internal procedure which includes risk identification and mitigation in accordance with ISO 14971. All verification testing has been completed and meets Siemens acceptance criteria. Additionally, all risks for the complete subject device have been identified and mitigated in accordingly.
The risk analysis was completed and risk control implemented to mitigate identified hazards. The testing results support that all the software specifications have met the acceptance criteria. Testing for verification and validation of the device was found acceptable to support the claims of substantial equivalence.
Software Documentation for a Moderate Level of Concern software per FDA's Guidance Document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" issued on May 11, 2005 is also included as part of this submission. The performance data demonstrates continued conformance with special controls for medical devices containing software. The Risk Analysis was completed and risk control implemented to mitigate identified hazards. The testing supports that all software specifications have met the acceptance criteria. Verification and validation testing supports the claims of substantial equivalence.
Siemens Healthcare conforms to the Cybersecurity requirements by implementing a process of preventing unauthorized access, modifications, misuse or denial of use, or the unauthorized use of information that is stored, accessed, or transferred from a medical device to an external recipient. Cybersecurity information in accordance with guidance document "Content of Premarket Submissions for Management of Cybersecurity Medical Devices issues on October 2, 2014" is included within this submission.
Performance tests were conducted to test the functionality of the syngo.CT View&GO. These tests have been performed to test the ability of the included features of the results of these tests demonstrate that the subject device performs as intended. The result of all conducted testing was found acceptable to support the claim of substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Image /page/0/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked one behind the other.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 28, 2017
Siemens Medical Solutions USA, Inc. Kimberly Mangum Regulatory Affairs Specialist 40 Libertv Blvd.. Mail Code 65-1 A Malvern, Pennsylvania 19355
Re: K170952
Trade/Device Name: syngo.CT View&GO Regulation Number: 21 CFR 892.2050 Regulation Name: Picture Archiving and Communications System Regulatory Class: Class II Product Code: LLZ Dated: March 21, 2017 Received: March 31, 2017
Dear Ms. Kimberly Mangum:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
1
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Michael D.'Hara
For
Robert A. Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K170952
Device Name
syngo.CT View&GO
Indications for Use (Describe)
syngo. CT View&GO is intended for basic visualization of medical images that are used for diagnostic purposes. The software package is designed to support trained technicians and trained physicians in basic qualitative and basic quantitative measurements as well as in the analysis of clinical data that has been acquired and reconstructed on Computed Tomography scanners. The software package shall also provide the possibility to save image data and to trigger the transfer of image data to other systems, such as printers or archiving systems. The software package shall provide an interface to integrate additional advanced visualization and measurement tools.
Basic visualization of medical images includes, for example:
- · Adjusting of windowing level presets
- · Zooming and panning of images
- · Multiplanar reconstruction (MPR) display
- · Maximum intensity projection (MIP) display
- · Volume rendering techniques (VRT) display
Basic qualitative and basic quantitative measurements include, for example:
- · Distance measurements
- · Region of interest (ROI) measurements
- · Pixel lens to measure local HU values
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the word "SIEMENS" in a sans-serif font. The word is in all capital letters and is a light blue color. The background is white. The letters are bold and evenly spaced.
510(K) SUMMARY FOR SYNGO.CT VIEW&GO
Submitted by: Siemens Medical Solutions USA, Inc. 40 Liberty Boulevard Malvern, PA 19355
Date Prepared: March 21, 2017
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
I. Submitter
Importer/Distributor Siemens Medical Solutions USA, Inc. 40 Liberty Boulevard Malvern, PA 19355
Establishment Registration Number 2240869
Manufacturing Site Siemens Healthcare GmbH Siemensstr. 1 D-91301 Forchheim, Germany
Establishment Registration Number 3004977335
Contact Person
Kimberly Mangum Regulatory Affairs Specialist Siemens Medical Solutions, Inc. USA 40 Liberty Boulevard Malvern, PA 19355 Phone: (610) 448 - 6477 Fax: (610) 640 - 4481 Email: kimberly.mangum@siemens.com
II. Device Name and Classification
| Product Name: | syngo.CT View&GO |
|---|---|
| Proprietary Name: | syngo.CT View&GO |
| Classification Name: | Picture Archiving and Communications System |
| Classification Panel: | Radiology |
| Secondary Classification Name: | Computed Tomography X-ray System |
| Secondary Classification Panel: | Radiology |
| CFR Section: | 21 CFR §892.2050 |
| Secondary CFR Section: | 21 CFR §892.1750 |
| Device Class: | Class II |
| Product Code: | LLZ |
| Secondary Product Code: | 90JAK |
III. Predicate Device
Primary Predicate Device: Trade Name: syngo®.via (version VB10A)
4
| 510(k) Number: | K150843 |
|---|---|
| Clearance Date: | 04/24/2015 |
| Classification Name: | Picture archiving and communications system |
| Classification Panel: | Radiology |
| CFR Section: | 21 CFR §892.2050 |
| Device Class: | Class II |
| Product Code: | LLZ |
| Recall Information: | There are currently no recalls for this device |
| Reference Device: | |
| Trade Name: | Fly Through |
| 510(k) Number: | K971717 |
| Clearance Date: | 09/03/1997 |
| Classification Name: | System, x-ray, tomography, computed |
| Classification Panel: | Radiology |
21 CFR §892.1750
Class II
JAK
IV. Device Description
CFR Section: Device Class:
Product Code:
The application syngo.CT View&GO is intended for basic visualization of medical images that are used for diagnostic purposes. It is designed to support trained technicians and trained physicians in basic qualitative and basic quantitative measurements as well as in the analysis of clinical data that has been acquired and reconstructed on Computed Tomography scanners. The application also provides the possibility to save image data and to trigger the transfer of image data to other systems, such as printers or archiving systems. In addition, syngo.CT View&GO provides an interface to integrate additional advanced post processing tools through the plug-in functionality of syngo.CT View&GO.
The application provides the basic visualization features (for example):
- Adjusting of windowing level presets ●
- Zooming and panning of images ●
- Multiplanar reconstruction (MPR) display ●
- . Maximum intensity projection (MIP) display
- Volume rendering techniques (VRT) display
Furthermore, basic qualitative and quantitative measurements are supported (for example):
- Distance measurements ●
- Region of interest (ROI) measurements ●
- Pixel lens to measure local HU values ●
syngo.CT View&GO also provides an interface to extend this application for additional advanced post processing tools through the plug-in functionality of syngo.CT View&GO.
This subject device contains the following modifications/improvements in comparison to the predicate device syngo®.via (version VB10A):
-
- New marketing name: syngo.CT View&GO
-
- Modified Indications for Use Statement
-
- Software version SOMARIS/8 VB20A which supports for following:
- o Extensibility (modified)
- Visualization tools (improved) o
- o Workflow and arrangement of commonly utilized tools (improved)
- Distribution of images in DICOM node (improved) O
The subject device syngo.CT View&GO is designed to operate on a syngo compatible host system (e.g. syngo.via VB20 software platform or higher). A comparison of these modifications with respect to the predicate device is provided in the "Comparison pf Technological Characteristics with the Predicate Device" section below.
5
SIEMENS
V. Indications for Use
syngo.CT View&GO is intended for basic visualization of medical images that are used for diagnostic purposes. The software package is designed to support trained technicians and trained physicians in basic qualitative and basic quantitative measurements as well as in the analysis of clinical data that has been acquired and reconstructed on Computed Tomography scanners. The software package shall also provide the possibility to save image data and to trigger the transfer of image data to other systems, such as printers or archiving systems. The software package shall provide an interface to integrate additional advanced visualization and measurement tools.
Basic visualization of medical images includes, for example:
- Adjusting of windowing level presets ●
- Zooming and panning of images o
- . Multiplanar reconstruction (MPR) display
- Maximum intensity projection (MIP) display .
- Volume rendering techniques (VRT) display .
Basic qualitative and basic quantitative measurements include, for example:
- Distance measurements ●
- Region of interest (ROI) measurements o
- Pixel lens to measure local HU values .
VI. Comparison of Technological Characteristics with the Predicate Device
Both the subject and predicate device have the same Intended Use, similar Indications for Use and the same visualization and measurement technological features. The minor differences between the subject and the predicate device are as follows:
- The Shaded Surface Display visualization feature has been improved by providing the possibility to fly through any hollow or tubular anatomical structures. This technology is not new and has been cleared with K971717 which is used as a reference device;
- The subject device includes workflow improvements (Tool Box / Favorite Tools and Distribution Step) to provide a faster access the tools of syngo.CT View&GO.
At a high-level, the subject and predicate device are based on the following same/similar technological characteristics:
| Feature | Subject Device | Predicate Device
(K150843) | Comparison Results |
|-------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------|
| Software | SOMARIS/8 VB20A | SOMARIS/8 VB10A | Subject device
supports a new
version of
SOMARIS/8
software. |
| Extensibility | Extendable via additional
post-processing tools | Extendable via additional post-
processing applications | The subject device
supports additional
post processing tools
that can be accessed
via plug-in
functionality |
| Visualization
Tools | Standard visualization tools
in conjunction with
Endoscopic View support
visualization inside hollow or
tubular anatomical structures
(such as airways and
intestines) | Standard visualization tools in
conjunction with Shaded Surface
Display | The subject device
has been modified to
support endoscopic
visualization inside
hollow tubular
anatomical
structures. |
| Measurement and
Annotation Tools | Standard measurement tools
(e. g. distance line) | Standard measurement tools
(e. g. distance line) | Same |
| Image Creation | Standard image creation tools
(e. g. radial ranges) | Standard image creation tools
(e. g. radial ranges) | Same |
| Printing | Basic printing functionality | Basic printing functionality | Same |
6
| Feature | Subject Device | Predicate Device
(K150843) | Comparison Results |
|----------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------|
| Image
Distribution and
Archiving | In the Distribution step it is
shown to which DICOM
nodes a series will be sent
when saving the case, or to
which node a series has
already been sent. The user
can select (or deselect)
whether a series will be sent
to any DICOM node or to a
subset of nodes. | Sending of DICOM data to
DICOM nodes possible in the
export functionality | The subject device
has been modified to
support transfer of a
series of data to any
DICOM node or a
subset of nodes. |
| Tool Organization | Functions are organized in the
Tool Area and Favorite
Tools. | Functions are organized in
corner menus and common
control area. | The subject device
measurement and
visualization
functions are
organized for easier
user access. |
| User Interface | syngo.via GUI | syngo.via GUI | Same |
| Archiving/Storing | CD-R, film, DVD, USB,
Network | CD-R, film, DVD, USB,
Network | Same |
| Communication | DICOM compatible | DICOM compatible | Same |
The subject device syngo.CT View&GO does not have significant changes in technological characteristics when compared to the predicate device. Any differences in technological characteristics do not raise different questions of safety and effectiveness. Overall, the subject device post-processing software functionality remains unchanged from the predicate device. The operating principle and the scientific technology are same. Testing and validation is completed. Test results show that the subject device, syngo.CT View&GO, is comparable to the predicate device in terms of technological characteristics and safety and effectiveness, therefore Siemens believes the subject device is substantially equivalent to the predicate device.
VII. Performance Data
The following performance data were provided in support of the substantial equivalence determination. This submission contains performance data to demonstrate conformance with special controls for medical devices containing software. Non-clinical tests (integration and functional) were conducted for syngo.CT View&GO during product development. The modifications described in this Premarket Notification were supported with verification/validation testing. Verification and Validation testing for the endoscopic view feature was conducted to demonstrate successful software integration and performance in accordance to Siemens internal procedure which includes risk identification and mitigation in accordance with ISO 14971. All verification testing has been completed and meets Siemens acceptance criteria. Additionally, all risks for the complete subject device have been identified and mitigated in accordingly.
Risk Analysis
The risk analysis was completed and risk control implemented to mitigate identified hazards. The testing results support that all the software specifications have met the acceptance criteria. Testing for verification and validation of the device was found acceptable to support the claims of substantial equivalence.
Software Verification and Validation
Software Documentation for a Moderate Level of Concern software per FDA's Guidance Document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" issued on May 11, 2005 is also included as part of this submission. The performance data demonstrates continued conformance with special controls for medical devices containing software. The Risk Analysis was completed and risk control implemented to mitigate identified hazards. The testing supports that all software specifications have met the acceptance criteria. Verification and validation testing supports the claims of substantial equivalence.
Siemens Healthcare conforms to the Cybersecurity requirements by implementing a process of preventing unauthorized access, modifications, misuse or denial of use, or the unauthorized use of
7
SIEMENS
information that is stored, accessed, or transferred from a medical device to an external recipient. Cybersecurity information in accordance with guidance document "Content of Premarket Submissions for Management of Cybersecurity Medical Devices issues on October 2, 2014" is included within this submission.
Non-Clinical Testing Summary
Performance tests were conducted to test the functionality of the syngo.CT View&GO. These tests have been performed to test the ability of the included features of the results of these tests demonstrate that the subject device performs as intended. The result of all conducted testing was found acceptable to support the claim of substantial equivalence.
| Recognition
Number | Product
Area | Title of Standard | Publication
Date | Standards
Development
Organization |
|-----------------------|--------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|------------------------------------------|
| 12-300 | Radiology | Digital Imaging and Communications in
Medicine (DICOM) Set; PS 3.1 – 3.20 | 06/27/2016 | NEMA |
| 13-32 | Software | Medical Device Software -Software Life
Cycle Processes; 62304:2006 (1st Edition) | 08/20/2012 | AAMI, ANSI,
IEC |
| 5-40 | Software/
Informatics | Medical devices – Application of risk
management to medical devices; 14971
Second Edition 2007-03-01 | 08/20/2012 | ISO |
| 5-95 | General I
(QS/RM) | Medical devices - Part 1: Application of
usability engineering to medical devices
IEC 62366-1:2015 | 06/27/2016 | IEC |
| 19-4 | General II
(ES/EMC) | AAMI / ANSI ES60601-1:2005/(R)2012 and
A1:2012, Medical electrical equipment - part
1: general requirements for basic safety and
essential performance (IEC 60601-1:2005,
mod) | 07/09/2014 | AAMI, ANSI |
General Safety and Effectiveness Concerns
The device labeling contains instructions for use and any necessary cautions and warnings to provide for safe and effective use of the device. Risk management is ensured via a hazard analysis, which is used to identify potential hazards. These potential hazards are controlled during development, verification and validation testing according to the Risk Management process. syngo.CT View&GO is designed to fulfill recognized and established industry practice and standards.
Summarv
The features described in this premarket notification are supported with verification and validation testing during product development. The risk analysis was completed and risk control implemented to mitigate identified hazards. The test results show that all of the software specifications have met the acceptance criteria. Verification and validation testing of the device was found acceptable to support the claim of substantial equivalence.
VIII. Conclusions
syngo.CT View&GO has the same intended use and a similar indication for use as the predicate device. The technological characteristics such as image visualization, operating platform, and image manipulation remain unchanged from the predicate device. The result of all testing conducted was found acceptable to support the claim of substantial equivalence. The predicate device was cleared based on non-clinical supportive information and clinical images. The results of these tests demonstrate that the predicate devices are adequate for the intended use. The comparison of technological characteristics, non-clinical performance data, and software validation demonstrates that the subject device is as safe and effective when compared to the predicate device that is currently marketed for the same intended use. For the subject device, syngo.CT View&GO, Siemens used the same testing with the same workflows as used to clear the predicate device. Since both devices were tested using the same methods, Siemens believes that the data generated from the syngo.CT View&GO testing supports a finding of substantial equivalence.